170.45
Schlusskurs vom Vortag:
$171.64
Offen:
$172.36
24-Stunden-Volumen:
582.86K
Relative Volume:
0.89
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+25.52%
1M Leistung:
+7.56%
6M Leistung:
+64.77%
1J Leistung:
+283.55%
Direxion Daily S P Biotech Bull 3 X Etf Stock (LABU) Company Profile
Firmenname
Direxion Daily S P Biotech Bull 3 X Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare LABU vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
LABU
Direxion Daily S P Biotech Bull 3 X Etf
|
170.45 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
325.21 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
658.93 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
661.86 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
265.51 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
588.50 | 124.43B | 0 | 0 | 0 | 0.00 |
Direxion Daily S P Biotech Bull 3 X Etf Aktie (LABU) Neueste Nachrichten
Stock List: Research Stocks from Around the World - GuruFocus
Direxion Daily S&P Biotech Bull 3X Shares (LABU) Stock Price, News, Quote & History - Yahoo! Finance Canada
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
Citigroup Jumps 3%: What’s Driving This Upward Momentum? - Bitget
ImmunityBio (IBRX) Plunges 10.3% Intraday: What's Triggering the Sharp Sell-Off? - Bitget
Direxion Daily FTSE Europe Bull 3X (EURL) ETF HoldersInstitutional Ownership - GuruFocus
Buy on the Dip Prospects: March 25 Edition - ETF Database
Direxion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0853 - MSN
Citigroup Jumps 2.6% Following Strategic Overhaul, Share Repurchases, and ETF Advantage — What Lies Ahead? - Bitget
LABU Stock Price, Quote & Chart | DRXN DLY S&P BT BL 3X ETF-UI (NYSEARCA:LABU) - ChartMill
SOXL vs. SSO: What Type of Investor Should Consider These Leveraged ETFs? - AOL.com
RETL,SWKS Volatility & Greeks - Finviz
RETL,SWKS Revenue Breakdown - Finviz
Liquidity Mapping Around (LABD) Price Events - Stock Traders Daily
Behavioral Patterns of LABU and Institutional Flows - Stock Traders Daily
Direxion Daily S&P Biotech Bull 3X Shares declares quarterly distribution of $0.9097 - MSN
Direxion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0370 - MSN
RETL,SWKS Options - Finviz
Why (LABD) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Direxion Daily FTSE China Bear 3X Shares (NYSEARCA:YANG) Short Interest Update - Defense World
(LABU) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Direxion Daily S&P Biotech Bear 3x Shares (LABD) Stock Trends and Sentiment 2026 - MarketBeat
Regional Bank Melt-Up: Is This 3X Leveraged Play the Ultimate High-Reward Bet? - AOL.com
Direxion Daily MSFT Bull 2X Shares (NASDAQ:MSFU) Shares Up 0.6%Should You Buy? - MarketBeat
Feeling Bearish? Try These ETFs That Take a Contrarian Approach - MarketBeat
Banking Crisis 2.0? The "Contagion" ETF That Gains 3% for Every 1% Banks Drop - AOL.com
Direxion Daily Energy Bull 2x Shares $ERX Shares Bought by Envestnet Asset Management Inc. - Defense World
QLD Offers Broader Tech Exposure Than SOXL - AOL.com
These 2 ETFs Have Been Red-Hot: Can it Continue? - AOL.com
Education Center - Direxion
Direxion Daily Real Estate Bull 3X Shares (NYSEARCA:DRN) Short Interest Up 21.8% in January - Defense World
Direxion Daily 7-10 Year Treasury Bull 3x Shares (NYSEARCA:TYD) Short Interest Down 13.5% in January - Defense World
TNA: Small-Caps Gain Momentum Over Mega-Cap Growth (NYSEARCA:TNA) - Seeking Alpha
EDC: A Highly Leveraged Play On The Daily Movements Of Emerging Markets (NYSEARCA:EDC) - Seeking Alpha
5 Small-cap Biotech ETFs to Watch - Investing News Network
A Leveraged Bet on the Broad Market or Big Tech: SPXL vs. QLD - The Motley Fool
Direxion Daily GOOGL Bull 2X Shares (NASDAQ:GGLL) Shares Gap DownTime to Sell? - MarketBeat
Short Interest in Direxion Daily GOOGL Bull 2X Shares (NASDAQ:GGLL) Grows By 25.2% - MarketBeat
LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD) - Seeking Alpha
Why This $6 Million Trim of a 3-Month Treasury ETF Might Signal a Shift in Cash Strategy - AOL.com
CURE: Benefits And Caveats Of The Leveraged Healthcare ETF (NYSEARCA:CURE) - Seeking Alpha
How Direxion Daily S&p Biotech Bull 3x Shares (LABU) Affects Rotational Strategy Timing - Stock Traders Daily
GUSH: Examining The Structure And Suitability Of This 2X Leveraged ETF - Seeking Alpha
LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF (NYSEARCA:LABU) - Seeking Alpha
NAIL: Favorable Macroeconomic Outlook For 2026-2027 (NYSEARCA:NAIL) - Seeking Alpha
SOXL: Time To Cash In (NYSEARCA:SOXL) - Seeking Alpha
Direxion Daily Financial Bull 3X Shares Breaks Below 200-Day Moving AverageNotable for FAS - Nasdaq
Short Interest in Direxion Daily MSCI Mexico Bull 3X Shares (NYSEARCA:MEXX) Increases By 45.8% - Defense World
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026 - AOL.com
Finanzdaten der Direxion Daily S P Biotech Bull 3 X Etf-Aktie (LABU)
Es liegen keine Finanzdaten für Direxion Daily S P Biotech Bull 3 X Etf (LABU) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):